NLRP3 and rheumatoid arthritis: Expression of NLRP3 is elevated in synovial tissues of RA patients and has been suggested to enhance the progression of RA [100,101]; thus, suppression of NLRP3 by JAK inhibitors seems to induce beneficial effects.